Haima Therapeutics is preparing to take SynthoPlate from the lab bench to human clinical trials. Built from Christa Pawlowski’s doctoral research at Case Western Reserve University, the synthetic platelets are designed to support the body’s natural clotting response. This feature explores the science, funding, military influence, and translational decisions behind Haima’s journey toward the clinic.